¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"cell labelling technique"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
cell labeling technique
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
inducer cell
À¯µµ¼¼Æ÷
inflammatory cell
¿°Áõ¼¼Æ÷
infundibular cell
±ò¶§±â¼¼Æ÷, ´©µÎ¼¼Æ÷
inner cell mass
¼Ó¼¼Æ÷µ¢ÀÌ, ³»¼¼Æ÷±«
intercalated cell
»çÀ̼¼Æ÷, °³Àç¼¼Æ÷
interdental cell
û°¢Ä¡¾Æ»çÀ̼¼Æ÷, Ä¡°£¼¼Æ÷
intermediate cell mass
Áß°£¼¼Æ÷µ¢ÀÌ, Áß°£¼¼Æ÷±«
interstitial cell
»çÀÌÁú¼¼Æ÷, °£Áú¼¼Æ÷
interstitial cell-stimulating hormone
»çÀÌÁú¼¼Æ÷ÀÚ±ØÈ£¸£¸ó, °£Áú¼¼Æ÷ÀÚ±ØÈ£¸£¸ó
interstitial plasma cell pneumonia
»çÀÌÁúÇüÁú¼¼Æ÷Æó·Å, ÆóÆ÷ÀÚÃæÁõ
Jurkat cell
Àúı¼¼Æ÷
juvenile cell
À¯¾à¼¼Æ÷
juxtaglomerular cell tumor
Å丮°ç¼¼Æ÷Á¾¾ç, »ç±¸Ã¼¿·¼¼Æ÷Á¾¾ç
Kupffer¡¯s cell
ÄíÆÛ¼¼Æ÷, º°Å«Æ÷½Ä¼¼Æ÷
killer cell
»ìÇØ¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
mononuclear cell
´ÜÇÙ¼¼Æ÷
mossy cell
À̳¢¼¼Æ÷
mother cell
¸ð¼¼Æ÷, ¾î¹Ì¼¼Æ÷
motor cell
¿îµ¿½Å°æ¼¼Æ÷
mucous cell
Á¡¾×¼¼Æ÷
mulberry cell
¿Àµð¼¼Æ÷
multinuclear giant cell
¹µÇÙ°Å´ë¼¼Æ÷
multipolar nerve cell
¹µ±Ø½Å°æ¼¼Æ÷
myeloid cell
(¢¡marrow cell) °ñ¼ö¼¼Æ÷
myeloma cell
°ñ¼öÁ¾¼¼Æ÷
myoepithelial cell
±ÙÀ°»óÇǼ¼Æ÷
myoid cell
À¯»ç±ÙÀ°¼¼Æ÷
natural killer cell
ÀÚ¿¬¼¼Æ÷µ¶¼º¼¼Æ÷, ÀÚ¿¬¼¼Æ÷µ¶¼º¼¼Æ÷
nerve cell
½Å°æ¼¼Æ÷
neural crest cell
½Å°æ´É¼±¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
hybridoma, T cell
T¼¼Æ÷ ÇÏÀ̺긮µµ¸¶
hypercomplex cell
Ãʺ¹ÇÕ¼¼Æ÷(õ±ÜÜùêá¬øà)
hypersensitivity reactions,type ii(antibody-dependent cell-mediate cyt
IIÇü
hypersensitivity reactions,type iv(cell-mediated)
IVÇü
hypersensitivity, cell-mediated
¼¼Æ÷¸Å°³ °ú¹Î¹ÝÀÀ
hypersensitized cell
°ú°¨ÀÛ¼¼Æ÷.
hypoglycemia, beta cell tumor
ÀúÇ÷´ç(Áõ), º£Å¸¼¼Æ÷Á¾
hypoxic cell
Àú»ê¼Ò¼¼Æ÷
hypoxic cell sensitizer
Àú»ê¼Ò¼¼Æ÷°¨ÀÛÁ¦
i-cell disease
I-¼¼Æ÷º´
idiotype specific regulatory cell
°³º°Æ¯ÀÌÇü Á¶Àý¼¼Æ÷
immortalized cell
¹«ÇÑÁõ½Ä¼¼Æ÷
immunity,cell-mediated
¼¼Æ÷¸Å°³¼º(á¬øàØÚË¿àõ)
immunocompetent cell
¸é¿ªÀû°Ý¼¼Æ÷.
immunodeficiency syndrome, cell mediated
¼¼Æ÷¸Å°³ ¸é¿ª°áÇÌ ÁõÈıº
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
cell division
¼¼Æ÷ºÐ¿
cell division
¼¼Æ÷ºÐ¿
cell division
¼¼Æ÷ºÐ¿
cell division
¼¼Æ÷ºÐ¿(¡ÝÂæñ).
cell division
¼¼Æ÷ºÐ¿
cell envelope
¼¼Æ÷¿ÜÇÇ
cell fusion
¼¼Æ÷À¶ÇÕ
cell fusion
¼¼Æ÷À¶ÇÕ(¡ë×ùê)
cell fusion
¼¼Æ÷À¶ÇÕ (¡ë×ùê)
cell growth
¼¼Æ÷¼ºÀå (¡à÷íþ)
cell growth pattern
¼¼Æ÷¼ºÀå¸ð¾ç<--¾ç½Ä>
cell growth,ligand receptor binding
¸®°£µå¼ö¿ë±â°áÇÕ (¡áôé»ÐïÌ¿ùê)
cell hybridization
¼¼Æ÷ÇÏÀ̺긮µå Çü¼º (¡û¡à÷)
cell inclusions
¼¼Æ÷Æ÷ÇÔ¹°
cell injury
¼¼Æ÷¼Õ»ó(¡áßß¿)
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½